Typology of Adherence in Adolescents: Phase II

CompletedOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

April 30, 2005

Study Completion Date

April 30, 2005

Conditions
HIV Infection
Trial Locations (17)

10021

Weill Medical College of Cornell University-New York Presbyterian Hospital, New York

10128

Mount Sinai Hospital, New York

10467

Montefiore Medical Center, The Bronx

19104

Children's Hospital of Philadelphia, Philadelphia

20010

Children's National Medical Center, Washington D.C.

21204

University of Maryland Medical School, Baltimore

21224

Johns Hopkins Hospital, Baltimore

33101

University of Miami, Miami

33316

Children's Diagnostic and Treatment Center, Fort Lauderdale

33606

University of South Florida, Tampa

60612

Stroger Hospital of Cook County, Chicago

70112

Tulane University, New Orleans

90027

Children's Hospital of Los Angeles, Los Angeles

92103

University of California at San Diego, San Diego

94143

University of California at San Francisco, San Francisco

02115

Childrens Hospital Boston, Boston

00936

University Pediatric Hospital, San Juan

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

National Institute of Mental Health (NIMH)

NIH

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

University of North Carolina, Chapel Hill

OTHER

NCT00106678 - Typology of Adherence in Adolescents: Phase II | Biotech Hunter | Biotech Hunter